—

RA CAPITAL MANAGEMENT, L.P.

Q1 2026 13F Holdings

  • Location
    boston, MA
  • Num holdings

    85

  • Value ($000)

    $9,437,744

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001346824
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ASND

ASCENDIS PHARMA A/S - ADR

SPONSORED ADR
04351P101
$2.35B
25 %

10,281,496

P
PCVX

VAXCYTE INC

COMMON STOCK
92243G108
$666.79M
7 %

11,474,599

R
RYTM

RHYTHM PHARMACEUTICALS INC

COMMON STOCK
76243J105
$579.81M
6 %

6,666,837

---

TYRA BIOSCIENCES INC

COMMON STOCK
90240B106
$467.21M
5 %

12,198,625

---

SIONNA THERAPEUTICS INC

COMMON STOCK
829401108
$397.09M
4 %

9,905,045

E
EWTX

EDGEWISE THERAPEUTICS INC

COMMON STOCK
28036F105
$328.5M
4 %

10,428,437

---

NEWAMSTERDAM PHARMA CO NV

COMMON STOCK
N62509109
$305.7M
3 %

9,550,191

N
NUVL

NUVALENT INC-A

COMMON STOCK
670703107
$259.62M
3 %

2,534,145

D
DNTH

DIANTHUS THERAPEUTICS INC

COMMON STOCK
252828108
$219.18M
2 %

2,611,733

M
MLYS

MINERALYS THERAPEUTICS INC

COMMON STOCK
603170101
$208.4M
2 %

7,692,750

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 85